News
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
First, the stock has sliced through two support levels. Shares broke through their 50-day moving average on Monday for the ...
Meanwhile, Novo had agreed supply deals with Hims and several of its larger rivals. The idea was to give their existing ...
The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...
Energy stocks posted declines after the [U.S. attacked Iranian nuclear facilities](http ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback